oncology

• red-flag presentations of solid tumours red-flag presentations urgency triage, organ-specific red flags (lung, CRC, gastroesophageal, breast, GU, gynae), biopsy strategy, baseline investigations, early supportive care, major pitfalls
  7 min 2026-07-30
• common solid tumours breast (ER/PR/HER2, tamoxifen vs. AI), lung (histology, driver mutations), CRC (staging, surveillance), prostate (ADT), testicular (orchiectomy, AFP), RCC (paraneoplastic)
  7 min 2026-08-10
• cancer of unknown primary workup, favourable vs unfavourable subsets, empiric treatment
  7 min 2026-08-17

• oncologic emergencies SVC syndrome, malignant spinal cord compression, brain metastases, hypercalcaemia of malignancy
  7 min 2026-08-10
• febrile neutropaenia 60-minute antibiotic bundle, MASCC stratification, antifungal escalation (haematology)
• tumour lysis syndrome Cairo-Bishop criteria, rasburicase, electrolyte management (haematology)

• immune checkpoint inhibitors checkpoint inhibitor agents PD-1/PD-L1/CTLA-4/LAG-3 agents, mechanisms, biomarkers (PD-L1, MSI-H), administration, special populations
  5 min 2026-08-13
• immune checkpoint inhibitor toxicity checkpoint inhibitor toxicity organ-specific irAEs, grading, steroid management, immune DKA, immune myocarditis
  7 min 2026-08-13

• cancer screening — Canadian guidelines Canadian screening guidelines breast, lung, CRC, cervical, HCC; PESTO (cancers not screened); tobacco cessation, alcohol
  4 min 2026-07-30

• chemotherapy toxicity reference toxicity reference drug-specific toxicities (anthracyclines, cisplatin, bleomycin, vincristine), radiation pneumonitis
  2 min 2026-07-30

[back to home](/)